Healthcare -
Biotechnology - NASDAQ - US
$ 6.7
-1.04 %
$ 60.6 M
Market Cap
-167.0
P/E
ICCC - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities ICCC - ImmuCell Corporation
2.88 M
LAST VALUE
60.85%
2 YEAR CAGR
-16.12%
5 YEAR CAGR
33.06%
10 YEAR CAGR